Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ02979
Aprutumab
1634620-63-5
95%
CFZ02978
Dezamizumab
1662664-56-3
95%
CFZ02977
Burosumab
1610833-03-8
95%
CFZ02976
Depatuxizumab
1471999-69-5
95%
CFZ02975
Fremanezumab
1655501-53-3
95%
CFZ02974
Eptinezumab
1644539-04-7
95%
CFZ02973
Lupartumab
1640971-88-5
95%
CFZ02972
Rozanolixizumab
1584645-37-3
95%
CFZ02960
Fianlimab
2126132-98-5
95%
CFZ02959
Atoltivimab
2135632-29-8
95%
Home
<<
···
16
17
18
19
20
···
18/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877